{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:04:46Z","timestamp":1774339486104,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.yebeh.2017.11.024","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T23:25:22Z","timestamp":1514244322000},"page":"130-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting"],"prefix":"10.1016","volume":"79","author":[{"given":"Francesc","family":"Sanmart\u00ed-Vilaplana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asunci\u00f3n","family":"D\u00edaz-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2017.11.024_bb0005","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/epi.12633","article-title":"A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy","volume":"55","author":"Tellez-Zenteno","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-3476(97)70027-1","article-title":"If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug?","volume":"131","author":"Camfield","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11910-007-0051-1","article-title":"Seizure-related injury and death","volume":"7","author":"Nei","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0020","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1528-1167.2011.03325.x","article-title":"Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments","volume":"52","author":"Luoni","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ana.21642","article-title":"Remission of epilepsy after two drug failures in children: a prospective study","volume":"65","author":"Berg","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.spen.2010.10.003","article-title":"New drugs for pediatric epilepsy","volume":"17","author":"Chu-Shore","year":"2010","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0035","author":"European Medicines Agency"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0040","author":"US Food and Drug Administration"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0045","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1517\/14656566.2012.713347","article-title":"Lacosamide in patients with pharmacoresistant epilepsy","volume":"13","author":"Verrotti","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0050","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial","volume":"50","author":"Halasz","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1528-1167.2009.02496.x","article-title":"Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial","volume":"51","author":"Chung","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0065","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.0b013e31826d5ec0","article-title":"Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review","volume":"79","author":"Pellock","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.seizure.2012.12.009","article-title":"Lacosamide in pediatric and adult patients: comparison of efficacy and safety","volume":"22","author":"Verrotti","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0075","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/epi.13466","article-title":"Lacosamide use in children with epilepsy: retention rate and effect of concomitant sodium channel blockers in a large cohort","volume":"57","author":"McGinnis","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jpc.12850","article-title":"Lacosamide as adjunctive therapy in treatment-resistant epilepsy in childhood","volume":"51","author":"Gulati","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejpn.2013.08.006","article-title":"Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11636260-000000000-00000","article-title":"Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain","volume":"12","author":"Casas-Fernandez","year":"2012","journal-title":"Drugs R D"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pediatrneurol.2010.12.003","article-title":"Experience with lacosamide in a series of children with drug-resistant focal epilepsy","volume":"44","author":"Guilhoto","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejpn.2011.08.007","article-title":"Preliminary efficacy and safety of lacosamide in children with refractory epilepsy","volume":"16","author":"Heyman","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0883073812436741","article-title":"Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study","volume":"27","author":"Rastogi","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0883073812462887","article-title":"Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy","volume":"29","author":"Yorns","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1684\/epd.2015.0782","article-title":"Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study","volume":"17","author":"Toupin","year":"2015","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0120","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jsps.2015.01.006","article-title":"Safety of lacosamide in children with refractory partial epilepsy","volume":"23","author":"Pasha","year":"2015","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0125","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/0883073816630084","article-title":"Efficacy and tolerability of lacosamide in the treatment of children with refractory generalized epilepsy","volume":"31","author":"Miskin","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0130","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/epi.12762","article-title":"Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24months in 347 children","volume":"55","author":"Orosz","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.nrl.2014.04.014","article-title":"Vagus nerve stimulator implantation for epilepsy in a paediatric hospital: outcomes and effect on quality of life","volume":"30","author":"Ulate-Campos","year":"2015","journal-title":"Neurologia"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ane.12221","article-title":"Efficacy and tolerability of add-on lacosamide in children with Lennox\u2013Gastaut syndrome","volume":"129","author":"Grosso","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0145","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00431-012-1813-6","article-title":"Diagnosis delay in West syndrome: misdiagnosis and consequences","volume":"171","author":"Auvin","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eplepsyres.2016.08.021","article-title":"Effectiveness and tolerability of perampanel in children and adolescents with refractory epilepsies\u2014an Italian observational multicenter study","volume":"127","author":"De Liso","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0155","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.seizure.2011.01.011","article-title":"Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1year","volume":"20","author":"Mills","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.11.024_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.seizure.2006.12.001","article-title":"Retention rate of levetiracetam in children with intractable epilepsy at 1year","volume":"16","author":"Peake","year":"2007","journal-title":"Seizure"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017307266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017307266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:27:39Z","timestamp":1761503259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017307266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":32,"alternative-id":["S1525505017307266"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.11.024","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}